PARD

Instituto Hermes Pardini S.A. Stock Price

BOVESPA:PARD3 Community·R$2.6b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

PARD3 Share Price Performance

R$0
0.00 (0.00%)
R$0
0.00 (0.00%)
Price R$0

PARD3 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Adequate balance sheet second-rate dividend payer.

1 Risk
1 Reward

Instituto Hermes Pardini S.A. Key Details

R$2.1b

Revenue

R$1.5b

Cost of Revenue

R$571.0m

Gross Profit

R$398.4m

Other Expenses

R$172.7m

Earnings

Last Reported Earnings
Dec 31, 2022
Next Reporting Earnings
n/a
1.36
27.21%
8.23%
53.3%
View Full Analysis

About PARD3

Founded
1959
Employees
7500
CEO
Roberto Meirelles
WebsiteView website
www.hermespardini.com.br

Instituto Hermes Pardini S.A., together with its subsidiaries, provides medical, dental, laboratory research, clinical analysis, and supplementary diagnostic and therapeutic services in Brazil. The company offers precision medicine, medical imaging, and unprecedented differentials in the field of forensic toxicology, occupational medicine, and clinical medicine, as well as sample collection services for clinical analysis tests, imaging tests, and vaccines. In addition, it engages in the resale of laboratory test supplies; personalized medicine diagnosis; and pathological anatomy business. The company primarily operates through Hermes Pardini, Padrão, Progenética, Diagnóstika, Cemedi, Centro de Medicina, Ecoar, Labclass Hermes Pardini, DLE, Toxicologia Pardini, Solução, APC, CLINICA DE IMAGEM, and Saúde Mob brand names. It serves hospitals, clinics, laboratories, and other companies in the health care sector. Instituto Hermes Pardini S.A. was founded in 1959 and is based in Belo Horizonte, Brazil.

Recent PARD3 News & Updates

Recent updates

No updates